ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
50.11
-0.88 (-1.73%)
At close: Mar 28, 2025, 4:00 PM
49.96
-0.15 (-0.29%)
After-hours: Mar 28, 2025, 6:48 PM EDT
BIB Holdings List
As of Mar 27, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 39.62% |
2 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 34.90% |
3 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 23.37% |
4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 10.10% |
5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 8.74% |
6 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 7.27% |
7 | VRTX | Vertex Pharmaceuticals Incorporated | 6.64% |
8 | AMGN | Amgen Inc. | 6.29% |
9 | GILD | Gilead Sciences, Inc. | 6.16% |
10 | REGN | Regeneron Pharmaceuticals, Inc. | 5.40% |
11 | AZN | AstraZeneca PLC | 3.35% |
12 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.77% |
13 | BIIB | Biogen Inc. | 1.62% |
14 | ARGX | argenx SE | 1.50% |
15 | SNY | Sanofi | 1.25% |
16 | SMMT | Summit Therapeutics Inc. | 1.20% |
17 | INSM | Insmed Incorporated | 1.11% |
18 | ITCI | Intra-Cellular Therapies, Inc. | 1.11% |
19 | BMRN | BioMarin Pharmaceutical Inc. | 1.10% |
20 | UTHR | United Therapeutics Corporation | 1.09% |
21 | RPRX | Royalty Pharma plc | 1.08% |
22 | ILMN | Illumina, Inc. | 1.03% |
23 | MRNA | Moderna, Inc. | 0.98% |
24 | INCY | Incyte Corporation | 0.93% |
25 | NBIX | Neurocrine Biosciences, Inc. | 0.90% |
26 | ONC | BeiGene, Ltd. | 0.87% |
27 | VTRS | Viatris Inc. | 0.83% |
28 | EXEL | Exelixis, Inc. | 0.81% |
29 | MEDP | Medpace Holdings, Inc. | 0.76% |
30 | ASND | Ascendis Pharma A/S | 0.75% |
31 | BNTX | BioNTech SE | 0.75% |
32 | PCVX | Vaxcyte, Inc. | 0.72% |
33 | TEM | Tempus AI, Inc. | 0.69% |
34 | HALO | Halozyme Therapeutics, Inc. | 0.63% |
35 | JAZZ | Jazz Pharmaceuticals plc | 0.61% |
36 | ROIV | Roivant Sciences Ltd. | 0.59% |
37 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.59% |
38 | RVMD | Revolution Medicines, Inc. | 0.56% |
39 | SRPT | Sarepta Therapeutics, Inc. | 0.55% |
40 | BBIO | BridgeBio Pharma, Inc. | 0.55% |
41 | AXSM | Axsome Therapeutics, Inc. | 0.47% |
42 | BPMC | Blueprint Medicines Corporation | 0.45% |
43 | GH | Guardant Health, Inc. | 0.44% |
44 | ALKS | Alkermes plc | 0.43% |
45 | KRYS | Krystal Biotech, Inc. | 0.42% |
46 | CYTK | Cytokinetics, Incorporated | 0.40% |
47 | VRNA | Verona Pharma plc | 0.40% |
48 | IONS | Ionis Pharmaceuticals, Inc. | 0.40% |
49 | NUVL | Nuvalent, Inc. | 0.38% |
50 | ADMA | ADMA Biologics, Inc. | 0.38% |
51 | PTCT | PTC Therapeutics, Inc. | 0.34% |
52 | RNA | Avidity Biosciences, Inc. | 0.31% |
53 | ACLX | Arcellx, Inc. | 0.30% |
54 | RARE | Ultragenyx Pharmaceutical Inc. | 0.28% |
55 | SWTX | SpringWorks Therapeutics, Inc. | 0.28% |
56 | AKRO | Akero Therapeutics, Inc. | 0.27% |
57 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.27% |
58 | CRSP | CRISPR Therapeutics AG | 0.26% |
59 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.26% |
60 | IMVT | Immunovant, Inc. | 0.25% |
61 | SRRK | Scholar Rock Holding Corporation | 0.25% |
62 | ALVO | Alvotech | 0.25% |
63 | MRUS | Merus N.V. | 0.24% |
64 | APLS | Apellis Pharmaceuticals, Inc. | 0.24% |
65 | PTGX | Protagonist Therapeutics, Inc. | 0.24% |
66 | LEGN | Legend Biotech Corporation | 0.23% |
67 | ACAD | ACADIA Pharmaceuticals Inc. | 0.23% |
68 | FOLD | Amicus Therapeutics, Inc. | 0.21% |
69 | XENE | Xenon Pharmaceuticals Inc. | 0.21% |
70 | AMRX | Amneal Pharmaceuticals, Inc. | 0.20% |
71 | TWST | Twist Bioscience Corporation | 0.20% |
72 | NAMS | NewAmsterdam Pharma Company N.V. | 0.19% |
73 | IBRX | ImmunityBio, Inc. | 0.19% |
74 | VCYT | Veracyte, Inc. | 0.19% |
75 | RXRX | Recursion Pharmaceuticals, Inc. | 0.19% |
76 | VCEL | Vericel Corporation | 0.18% |
77 | ZLAB | Zai Lab Limited | 0.18% |
78 | MIRM | Mirum Pharmaceuticals, Inc. | 0.18% |
79 | EWTX | Edgewise Therapeutics, Inc. | 0.18% |
80 | LGND | Ligand Pharmaceuticals Incorporated | 0.17% |
81 | NVCR | NovoCure Limited | 0.16% |
82 | DNLI | Denali Therapeutics Inc. | 0.16% |
83 | CGON | CG Oncology, Inc. | 0.16% |
84 | KYMR | Kymera Therapeutics, Inc. | 0.15% |
85 | TARS | Tarsus Pharmaceuticals, Inc. | 0.15% |
86 | HRMY | Harmony Biosciences Holdings, Inc. | 0.15% |
87 | ARQT | Arcutis Biotherapeutics, Inc. | 0.15% |
88 | BEAM | Beam Therapeutics Inc. | 0.15% |
89 | IRON | Disc Medicine, Inc. | 0.14% |
90 | SUPN | Supernus Pharmaceuticals, Inc. | 0.14% |
91 | TVTX | Travere Therapeutics, Inc. | 0.14% |
92 | AGIO | Agios Pharmaceuticals, Inc. | 0.14% |
93 | APGE | Apogee Therapeutics, Inc. | 0.14% |
94 | JANX | Janux Therapeutics, Inc. | 0.14% |
95 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.14% |
96 | DVAX | Dynavax Technologies Corporation | 0.13% |
97 | VERA | Vera Therapeutics, Inc. | 0.13% |
98 | BCRX | BioCryst Pharmaceuticals, Inc. | 0.13% |
99 | MNKD | MannKind Corporation | 0.12% |
100 | IDYA | IDEAYA Biosciences, Inc. | 0.12% |
101 | ANIP | ANI Pharmaceuticals, Inc. | 0.12% |
102 | WVE | Wave Life Sciences Ltd. | 0.11% |
103 | AMPH | Amphastar Pharmaceuticals, Inc. | 0.11% |
104 | DYN | Dyne Therapeutics, Inc. | 0.11% |
105 | CNTA | Centessa Pharmaceuticals plc | 0.10% |
106 | ETNB | 89bio, Inc. | 0.10% |
107 | SPRY | ARS Pharmaceuticals, Inc. | 0.10% |
108 | ARDX | Ardelyx, Inc. | 0.10% |
109 | OCUL | Ocular Therapeutix, Inc. | 0.10% |
110 | INDV | Indivior PLC | 0.10% |
111 | ADPT | Adaptive Biotechnologies Corporation | 0.10% |
112 | IMCR | Immunocore Holdings plc | 0.09% |
113 | IOVA | Iovance Biotherapeutics, Inc. | 0.09% |
114 | GPCR | Structure Therapeutics Inc. | 0.09% |
115 | PCRX | Pacira BioSciences, Inc. | 0.09% |
116 | NVAX | Novavax, Inc. | 0.09% |
117 | AUPH | Aurinia Pharmaceuticals Inc. | 0.09% |
118 | SNDX | Syndax Pharmaceuticals, Inc. | 0.09% |
119 | INVA | Innoviva, Inc. | 0.09% |
120 | SYRE | Spyre Therapeutics, Inc. | 0.08% |
121 | ELVN | Enliven Therapeutics, Inc. | 0.08% |
122 | GERN | Geron Corporation | 0.08% |
123 | TXG | 10x Genomics, Inc. | 0.08% |
124 | HROW | Harrow, Inc. | 0.08% |
125 | KNSA | Kiniksa Pharmaceuticals International, plc | 0.08% |
126 | GRAL | GRAIL, Inc. | 0.08% |
127 | NRIX | Nurix Therapeutics, Inc. | 0.08% |
128 | COLL | Collegium Pharmaceutical, Inc. | 0.07% |
129 | VIR | Vir Biotechnology, Inc. | 0.07% |
130 | GRFS | Grifols, S.A. | 0.07% |
131 | NTLA | Intellia Therapeutics, Inc. | 0.07% |
132 | ZYME | Zymeworks Inc. | 0.07% |
133 | GMAB | Genmab A/S | 0.07% |
134 | RCKT | Rocket Pharmaceuticals, Inc. | 0.07% |
135 | XERS | Xeris Biopharma Holdings, Inc. | 0.07% |
136 | DAWN | Day One Biopharmaceuticals, Inc. | 0.07% |
137 | AVXL | Anavex Life Sciences Corp. | 0.06% |
138 | XNCR | Xencor, Inc. | 0.06% |
139 | REPL | Replimune Group, Inc. | 0.06% |
140 | PRAX | Praxis Precision Medicines, Inc. | 0.06% |
141 | AVDL | Avadel Pharmaceuticals plc | 0.06% |
142 | EOLS | Evolus, Inc. | 0.06% |
143 | COGT | Cogent Biosciences, Inc. | 0.06% |
144 | FTRE | Fortrea Holdings Inc. | 0.06% |
145 | MLYS | Mineralys Therapeutics, Inc. | 0.06% |
146 | LENZ | LENZ Therapeutics, Inc. | 0.06% |
147 | QURE | uniQure N.V. | 0.06% |
148 | ABCL | AbCellera Biologics Inc. | 0.06% |
149 | PRTA | Prothena Corporation plc | 0.06% |
150 | CVAC | CureVac N.V. | 0.05% |
151 | AVBP | ArriVent BioPharma, Inc. | 0.05% |
152 | ABUS | Arbutus Biopharma Corporation | 0.05% |
153 | KALV | KalVista Pharmaceuticals, Inc. | 0.05% |
154 | TRVI | Trevi Therapeutics, Inc. | 0.05% |
155 | MGTX | MeiraGTx Holdings plc | 0.05% |
156 | KURA | Kura Oncology, Inc. | 0.05% |
157 | CSTL | Castle Biosciences, Inc. | 0.05% |
158 | ANAB | AnaptysBio, Inc. | 0.05% |
159 | ARVN | Arvinas, Inc. | 0.04% |
160 | SAGE | Sage Therapeutics, Inc. | 0.04% |
161 | OMER | Omeros Corporation | 0.04% |
162 | RLAY | Relay Therapeutics, Inc. | 0.04% |
163 | TYRA | Tyra Biosciences, Inc. | 0.04% |
164 | CGEM | Cullinan Therapeutics, Inc. | 0.04% |
165 | URGN | UroGen Pharma Ltd. | 0.04% |
166 | PGEN | Precigen, Inc. | 0.04% |
167 | SVRA | Savara Inc. | 0.04% |
168 | HCM | HUTCHMED (China) Limited | 0.04% |
169 | MNMD | Mind Medicine (MindMed) Inc. | 0.04% |
170 | VERV | Verve Therapeutics, Inc. | 0.04% |
171 | TBPH | Theravance Biopharma, Inc. | 0.04% |
172 | PHAT | Phathom Pharmaceuticals, Inc. | 0.04% |
173 | MESO | Mesoblast Limited | 0.04% |
174 | ORKA | Oruka Therapeutics, Inc. | 0.04% |
175 | ORIC | ORIC Pharmaceuticals, Inc. | 0.04% |
176 | KROS | Keros Therapeutics, Inc. | 0.04% |
177 | PAHC | Phibro Animal Health Corporation | 0.03% |
178 | ERAS | Erasca, Inc. | 0.03% |
179 | TRML | Tourmaline Bio, Inc. | 0.03% |
180 | ALT | Altimmune, Inc. | 0.03% |
181 | ZVRA | Zevra Therapeutics, Inc. | 0.03% |
182 | SANA | Sana Biotechnology, Inc. | 0.03% |
183 | CRMD | CorMedix Inc. | 0.03% |
184 | BCYC | Bicycle Therapeutics plc | 0.03% |
185 | EYPT | EyePoint Pharmaceuticals, Inc. | 0.03% |
186 | SIGA | SIGA Technologies, Inc. | 0.03% |
187 | STOK | Stoke Therapeutics, Inc. | 0.03% |
188 | RGNX | REGENXBIO Inc. | 0.03% |
189 | TSHA | Taysha Gene Therapies, Inc. | 0.03% |
190 | TRDA | Entrada Therapeutics, Inc. | 0.03% |
191 | GLPG | Galapagos NV | 0.03% |
192 | RNAC | Cartesian Therapeutics, Inc. | 0.03% |
193 | RAPP | Rapport Therapeutics, Inc. | 0.03% |
194 | ATXS | Astria Therapeutics, Inc. | 0.03% |
195 | PACB | Pacific Biosciences of California, Inc. | 0.03% |
196 | SLDB | Solid Biosciences Inc. | 0.03% |
197 | MRVI | Maravai LifeSciences Holdings, Inc. | 0.03% |
198 | AMLX | Amylyx Pharmaceuticals, Inc. | 0.03% |
199 | AUTL | Autolus Therapeutics plc | 0.03% |
200 | ALLO | Allogene Therapeutics, Inc. | 0.03% |
201 | ARCT | Arcturus Therapeutics Holdings Inc. | 0.03% |
202 | RIGL | Rigel Pharmaceuticals, Inc. | 0.03% |
203 | GLUE | Monte Rosa Therapeutics, Inc. | 0.03% |
204 | ABSI | Absci Corporation | 0.03% |
205 | ESPR | Esperion Therapeutics, Inc. | 0.03% |
206 | PSNL | Personalis, Inc. | 0.02% |
207 | OLMA | Olema Pharmaceuticals, Inc. | 0.02% |
208 | OABI | OmniAb, Inc. | 0.02% |
209 | MXCT | MaxCyte, Inc. | 0.02% |
210 | AURA | Aura Biosciences, Inc. | 0.02% |
211 | AQST | Aquestive Therapeutics, Inc. | 0.02% |
212 | TKNO | Alpha Teknova, Inc. | 0.02% |
213 | TECX | Tectonic Therapeutic, Inc. | 0.02% |
214 | VNDA | Vanda Pharmaceuticals Inc. | 0.02% |
215 | SLRN | Acelyrin, Inc. | 0.02% |
216 | TERN | Terns Pharmaceuticals, Inc. | 0.02% |
217 | PRME | Prime Medicine, Inc. | 0.02% |
218 | HUMA | Humacyte, Inc. | 0.02% |
219 | TSVT | 2seventy bio, Inc. | 0.02% |
220 | AVIR | Atea Pharmaceuticals, Inc. | 0.02% |
221 | ITOS | iTeos Therapeutics, Inc. | 0.02% |
222 | CDXS | Codexis, Inc. | 0.02% |
223 | ANNX | Annexon, Inc. | 0.02% |
224 | DSGN | Design Therapeutics, Inc. | 0.02% |
225 | IRWD | Ironwood Pharmaceuticals, Inc. | 0.02% |
226 | NGNE | Neurogene Inc. | 0.02% |
227 | YMAB | Y-mAbs Therapeutics, Inc. | 0.02% |
228 | ALMS | Alumis Inc. | 0.02% |
229 | CRVS | Corvus Pharmaceuticals, Inc. | 0.02% |
230 | FHTX | Foghorn Therapeutics Inc. | 0.02% |
231 | TVGN | Tevogen Bio Holdings Inc. | 0.02% |
232 | INBX | Inhibrx Biosciences, Inc. | 0.02% |
233 | VYGR | Voyager Therapeutics, Inc. | 0.02% |
234 | ACIU | AC Immune SA | 0.02% |
235 | CRGX | CARGO Therapeutics, Inc. | 0.02% |
236 | CMPS | COMPASS Pathways plc | 0.02% |
237 | AMRN | Amarin Corporation plc | 0.01% |
238 | NMRA | Neumora Therapeutics, Inc. | 0.01% |
239 | TNGX | Tango Therapeutics, Inc. | 0.01% |
240 | SLN | Silence Therapeutics plc | 0.01% |
241 | LYEL | Lyell Immunopharma, Inc. | 0.01% |
242 | FDMT | 4D Molecular Therapeutics, Inc. | 0.01% |
243 | THRD | Third Harmonic Bio, Inc. | 0.01% |
244 | LRMR | Larimar Therapeutics, Inc. | 0.01% |
245 | SCPH | scPharmaceuticals Inc. | 0.01% |
246 | NKTX | Nkarta, Inc. | 0.01% |
247 | LXEO | Lexeo Therapeutics, Inc. | 0.01% |
248 | ALEC | Alector, Inc. | 0.01% |
249 | CCCC | C4 Therapeutics, Inc. | 0.01% |
250 | LXRX | Lexicon Pharmaceuticals, Inc. | 0.01% |
251 | ENTA | Enanta Pharmaceuticals, Inc. | 0.01% |
252 | EDIT | Editas Medicine, Inc. | 0.01% |
253 | KYTX | Kyverna Therapeutics, Inc. | 0.01% |
254 | FATE | Fate Therapeutics, Inc. | 0.01% |
255 | MGNX | MacroGenics, Inc. | 0.01% |
256 | PLRX | Pliant Therapeutics, Inc. | 0.01% |
257 | BMEA | Biomea Fusion, Inc. | 0.01% |
258 | ARTV | Artiva Biotherapeutics, Inc. | 0.01% |
259 | CLYM | Climb Bio, Inc. | 0.01% |
260 | ACRV | Acrivon Therapeutics, Inc. | 0.01% |
261 | TCRX | TScan Therapeutics, Inc. | 0.01% |
262 | PYXS | Pyxis Oncology, Inc. | 0.01% |
263 | INZY | Inozyme Pharma, Inc. | 0.01% |
264 | APLT | Applied Therapeutics, Inc. | undefined |
265 | STRO | Sutro Biopharma, Inc. | undefined |
266 | OKUR | OnKure Therapeutics, Inc. | undefined |
267 | PEPG | PepGen Inc. | undefined |
268 | MRSN | Mersana Therapeutics, Inc. | undefined |
269 | IGMS | IGM Biosciences, Inc. | undefined |
270 | 2324462D | CARTESIAN THERAPEUTICS-CVR | undefined |
271 | QTTB | Q32 Bio Inc. | undefined |
272 | B 0 04.01.25 | TREASURY BILL | undefined |
273 | n/a | TREASURY BILL | undefined |
274 | n/a | NET OTHER ASSETS (LIABILITIES) | undefined |
As of Mar 27, 2025